| 0 (0%) | 01-19 18:54 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.23 |
1-year : | 5.84 |
| Resists | First : | 3.62 |
Second : | 5 |
| Pivot price | 2.27 |
|||
| Supports | First : | 1.4 |
Second : | 1.17 |
| MAs | MA(5) : | 2.01 |
MA(20) : | 2.49 |
| MA(100) : | 4.86 |
MA(250) : | 19.15 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 9.9 |
D(3) : | 13.6 |
| RSI | RSI(14): 24.3 |
|||
| 52-week | High : | 162.5 | Low : | 1.4 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NAOV ] has closed below the lower bollinger band by 15.4%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 46% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.57 - 1.58 | 1.58 - 1.59 |
| Low: | 1.39 - 1.4 | 1.4 - 1.41 |
| Close: | 1.44 - 1.46 | 1.46 - 1.48 |
Sun, 18 Jan 2026
Buy Signal: What is the dividend yield of NAOV - July 2025 PreEarnings & AI Forecast Swing Trade Picks - baoquankhu1.vn
Wed, 14 Jan 2026
ENvue Medical Launches Over-the-Counter ENFit Syringes for Enhanced Enteral Care Solutions - Quiver Quantitative
Tue, 13 Jan 2026
Weekly Earnings: How NAOV stock performs after earnings - July 2025 Movers & AI Enhanced Execution Alerts - Bộ Nội Vụ
Fri, 12 Dec 2025
NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol - Investing.com
Sun, 07 Dec 2025
Would You Still Hold NanoVibronix Stock If It Fell Another 30%? - Trefis
Mon, 15 Sep 2025
NanoVibronix (NAOV) Secures New Patent for Medical Device Techno - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 0.7 (%) |
| Held by Institutions | 0.5 (%) |
| Shares Short | 23 (K) |
| Shares Short P.Month | 43 (K) |
| EPS | -51.82 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 42 |
| Profit Margin | -252 % |
| Operating Margin | -311.3 % |
| Return on Assets (ttm) | -20 % |
| Return on Equity (ttm) | -30.6 % |
| Qtrly Rev. Growth | 92 % |
| Gross Profit (p.s.) | 0.73 |
| Sales Per Share | 2.46 |
| EBITDA (p.s.) | -8.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -0.03 |
| PEG Ratio | 0 |
| Price to Book value | 0.03 |
| Price to Sales | 0.59 |
| Price to Cash Flow | -0.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|